Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Drug policy

Economic evaluation of anti-malarial drug policies across presidential regimes in Nigeria: A comparative analysis from 1999 to present

Chukwuka Elendu

published 11 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

The practice of drug emergency supply in China during the COVID-19 pandemic: A policy mix perspective

Zhang Jie-ying, Li Jun, Wang Xue-ya, Fan Rui-xue, Zhao Feng, Tang Yi, Zhang Jun-lin, Mao Ning-ying

published 30 Dec 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Impact of pregabalin reclassification as a controlled substance in Egypt on gabapentinoid and opioid utilization: A repeated cross-sectional study

Araniy Santhireswaran, Simon LaRue, Shanzeh Chaudhry, Yilei Liu, Katie Suda, Omneya Mohamed, Mohamed Amin, Jason Guertin, Mina Tadrous

published 05 Dec 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Pharmaceutical expenditure changes under the volume-based procurement policy: Effects and influencing factors

Ying Yang, Yuanhui Duan, Lei Zhou, Sisheng Gan, Zongfu Mao, Furong Wang

published 14 Aug 2025

Loading metrics information...

Metrics unavailable. Please check back later.

R&D investment and total factor productivity in China’s pharmaceutical industry: The moderating effect of the centralized procurement policy

Xiujuan Li, Jiachun Xu

published 19 May 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Canadian newspaper coverage on harm reduction featuring bereaved mothers: A mixed methods analysis

Heather Morris, T. Cameron Wild, Marina Giovannoni, Rebecca Haines-Saah, Jakob Koziel, Petra Schulz, Hauwa Bwala, Diane Kunyk, Tania Bubela, Elaine Hyshka

published 27 Nov 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Sociometric network analysis in illicit drugs research: A scoping review

Naomi Zakimi, Alissa Greer, Martin Bouchard, Arshpreet Dhillon, Alison Ritter

published 27 Feb 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID

Beth E. Meyerson, Keith G. Bentele, Danielle M. Russell, Benjamin R. Brady, Missy Downer, Roberto C. Garcia, Irene Garnett, Rebecca Lutz, Arlene Mahoney, Savannah Samorano, Christina Arredondo, Honey J. Andres, Haley Coles, Brenda Granillo

published 25 Oct 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Restriction on antimicrobial dispensing without prescription on a national level: Impact on the overall antimicrobial utilization in the community pharmacies in Saudi Arabia

Ahmed Hamdan Al-Jedai, Yasser Almogbel, Khalid Eljaaly, Nasser M. Alqahtani, Hajer Yousef Almudaiheem, Nancy Awad, Dema Abdulrahman Alissa, Abdullah Assiri, Tareef Alaama

published 26 Jul 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Estimating the effects of legalizing recreational cannabis on newly incident cannabis use

Barrett Wallace Montgomery, Meaghan H. Roberts, Claire E. Margerison, James C. Anthony

published 21 Jul 2022

Loading metrics information...

Metrics unavailable. Please check back later.

The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data

Adam Palayew, Samya R. Stumo, Graham S. Cooke, Sharon J. Hutchinson, Marie Jauffret-Roustide, Mojca Maticic, Magdalena Harris, Ammal M. Metwally, Homie Razavi, Jeffrey V. Lazarus, on behalf of the Hep-CORE Study Group

published 28 Jul 2020

Loading metrics information...

Metrics unavailable. Please check back later.

Identifying the most effective essential medicines policies for quality use of medicines: A replicability study using three World Health Organisation data-sets

Kathleen Anne Holloway, Verica Ivanovska, Solaiappan Manikandan, Mathaiyan Jayanthi, Anbarasan Mohan, Gilles Forte, David Henry

published 06 Feb 2020

Loading metrics information...

Metrics unavailable. Please check back later.

Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden

Jessica Neicun, Marthe Steenhuizen, Robin van Kessel, Justin C. Yang, Attilio Negri, Katarzyna Czabanowska, Ornella Corazza, Andres Roman-Urrestarazu

published 26 Jun 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Drug policy

You can change these options by clicking profile then "Alerts and Notifications"